SEARCH

SEARCH BY CITATION

References

  • 1
    Poupot, M. and Fournie, J. J., Non-peptide antigens activating human Vgamma9/Vdelta2 T lymphocytes. Immunol. Lett. 2004. 95: 129138.
  • 2
    Bonneville, M. and Scotet, E., Human Vgamma9Vdelta2 T-cells: promising new leads for immunotherapy of infections and tumors. Curr. Opin. Immunol. 2006. 18: 539546.
  • 3
    Ismaili, J., Olislagers, V., Poupot, R., Fournie, J. J. and Goldman, M., Human gamma delta T-cells induce dendritic cell maturation. Clin. Immunol. 2002. 103: 296302.
  • 4
    Dieli, F., Caccamo, N., Meraviglia, S., Ivanyi, J., Sireci, G., Bonanno, C. T., Ferlazzo, V. et al., Reciprocal stimulation of gammadelta T-cells and dendritic cells during the anti-mycobacterial immune response. Eur. J. Immunol. 2004. 34: 32273235.
  • 5
    Devilder, M. C., Maillet, S., Bouyge-Moreau, I., Donnadieu, E., Bonneville, M. and Scotet, E., Potentiation of antigen-stimulated V gamma 9V delta 2 T-cell cytokine production by immature dendritic cells (DC) and reciprocal effect on DC maturation. J. Immunol. 2006. 176: 13861393.
  • 6
    Dieli, F., Poccia, F., Lipp, M., Sireci, G., Caccamo, N., Di Sano, C. and Salerno, A., Differentiation of effector/memory Vdelta2 T-cells and migratory routes in lymph nodes or inflammatory sites. J. Exp. Med. 2003. 198: 391397.
  • 7
    Angelini, D. F., Borsellino, G., Poupot, M., Diamantini, A., Poupot, R., Bernardi, G., Poccia, F. et al., FcgammaRIII discriminates between 2 subsets of Vgamma9Vdelta2 effector cells with different responses and activation pathways. Blood 2004. 104: 18011807.
  • 8
    Caccamo, N., Battistini, L., Bonneville, M., Poccia, F., Fournie, J. J., Meraviglia, S., Borsellino, G. et al., CXCR5 identifies a subset of Vgamma9Vdelta2 T-cells which secrete IL-4 and IL-10 and help B cells for antibody production. J. Immunol. 2006. 177: 52905295.
  • 9
    Shen, Y., Zhou, D., Qiu, L., Lai, X., Simon, M., Shen, L., Kou, Z. et al., Adaptive immune response of Vgamma2Vdelta2+ T-cells during mycobacterial infections. Science 2002. 295: 22552258.
  • 10
    Worku, S., Gorse, G. J., Belshe, R. B. and Hoft, D. F., Canarypox vaccines induce antigen-specific human gammadelta T-cells capable of interferon-gamma production. J. Infect. Dis. 2001. 184: 525532.
  • 11
    Agrati, C., Castilletti, C., De Santis, R., Cimini, E., Bordi, L., Malkovsky, M., Poccia, F. and Capobianchi, M. R., Interferon-gamma-mediated antiviral immunity against orthopoxvirus infection is provided by gamma delta T-cells. J. Infect. Dis. 2006. 193: 16061607; author reply 1607–1608.
  • 12
    Espinosa, E., Belmant, C., Pont, F., Luciani, B., Poupot, R., Romagne, F., Brailly, H. et al., Chemical synthesis and biological activity of bromohydrin pyrophosphate, a potent stimulator of human gamma delta T-cells. J. Biol. Chem. 2001. 276: 1833718344.
  • 13
    Cendron, D., Ingoure, S., Martino, A., Casetti, R., Horand, F., Romagne, F., Sicard, H. et al., A tuberculosis vaccine based on phosphoantigens and fusion proteins induces distinct gammadelta and alphabeta T-cell responses in primates. Eur. J. Immunol. 2007. 37: 549565.
  • 14
    Sicard, H., Ingoure, S., Luciani, B., Serraz, C., Fournie, J. J., Bonneville, M., Tiollier, J. and Romagne, F., In vivo immunomanipulation of V gamma 9V delta 2 T-cells with a synthetic phosphoantigen in a preclinical nonhuman primate model. J. Immunol. 2005. 175: 54715480.
  • 15
    Kobayashi, H., Tanaka, Y., Yagi, J., Toma, H. and Uchiyama, T., Gamma/delta T-cells provide innate immunity against renal cell carcinoma. Cancer Immunol. Immunother. 2001. 50: 115124.
  • 16
    Kunzmann, V. and Wilhelm, M., Anti-lymphoma effect of gammadelta T-cells. Leuk. Lymphoma 2005. 46: 671680.
  • 17
    Lamb, L. S., Jr. and Lopez, R. D., Gammadelta T-cells: a new frontier for immunotherapy? Biol. Blood Marrow Transplant. 2005. 11: 161168.
  • 18
    Viey, E., Fromont, G., Escudier, B., Morel, Y., Da Rocha, S., Chouaib, S. and Caignard, A., Phosphostim-activated gamma delta T-cells kill autologous metastatic renal cell carcinoma. J. Immunol. 2005. 174: 13381347.
  • 19
    Rabinovich, G. A., Gabrilovich, D. and Sotomayor, E. M., Immunosuppressive strategies that are mediated by tumor cells. Annu. Rev. Immunol. 2007. 25: 267296.
  • 20
    Hall, B. Andreeff, M. and Marini, F., The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles. Handb. Exp. Pharmacol. 2007. 180: 263283.
  • 21
    Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L. et al., Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007. 449: 557563.
  • 22
    Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A. et al., Multilineage potential of adult human mesenchymal stem cells. Science 1999. 284: 143147.
  • 23
    Barry, F. P., Biology and clinical applications of mesenchymal stem cells. Birth Defects Res. C Embryo Today 2003. 69: 250256.
  • 24
    Jorgensen, C., Djouad, F., Apparailly, F. and Noel, D., Engineering mesenchymal stem cells for immunotherapy. Gene Ther. 2003. 10: 928931.
  • 25
    Di Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P. D., Matteucci, P., Grisanti, S. and Gianni, A. M., Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002. 99: 38383843.
  • 26
    Glennie, S., Soeiro, I., Dyson, P. J., Lam, E. W. and Dazzi, F., Bone marrow mesenchymal stem cells induce division arrest anergy of activated T-cells. Blood 2005. 105: 28212827.
  • 27
    Krampera, M., Glennie, S., Dyson, J., Scott, D., Laylor, R., Simpson, E. and Dazzi, F., Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T-cells to their cognate peptide. Blood 2003. 101: 37223729.
  • 28
    Sotiropoulou, P. A., Perez, S. A., Gritzapis, A. D., Baxevanis, C. N., Papamichail, M., Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells 2006. 24: 7485.
  • 29
    Spaggiari, G. M., Capobianco, A., Becchetti, S., Mingari, M. C. and Moretta, L., Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 2006. 107: 14841490.
  • 30
    Aggarwal, S. and Pittenger, M. F., Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005. 105: 18151822.
  • 31
    Nauta, A. J., Kruisselbrink, A. B., Lurvink, E., Willemze, R. and Fibbe, W. E., Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells. J. Immunol. 2006. 177: 20802087.
  • 32
    Uccelli, A., Moretta, L. and Pistoia, V., Immunoregulatory function of mesenchymal stem cells. Eur. J. Immunol. 2006. 36: 25662573.
  • 33
    Djouad, F., Plence, P., Bony, C., Tropel, P., Apparailly, F., Sany, J., Noel, D. and Jorgensen, C., Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003. 102: 38373844.
  • 34
    Chen, L., Cencioni, M. T., Angelini, D. F., Borsellino, G., Battistini, L. and Brosnan, C. F., Transcriptional profiling of gamma delta T-cells identifies a role for vitamin D in the immunoregulation of the V gamma 9V delta 2 response to phosphate-containing ligands. J. Immunol. 2005. 174: 61446152.
  • 35
    Rojas, R. E., Balaji, K. N., Subramanian, A. and Boom, W. H., Regulation of human CD4(+) alphabeta T-cell-receptor-positive (TCR(+)) and gammadelta TCR(+) T-cell responses to Mycobacterium tuberculosis by interleukin-10 and transforming growth factor beta. Infect. Immun. 1999. 67: 64616472.
  • 36
    Gober, H. J., Kistowska, M., Angman, L., Jeno, P., Mori, L. and De Libero, G., Human T-cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells. J. Exp. Med. 2003. 197: 163168.
  • 37
    Bygdeman, M., Pharmacokinetics of prostaglandins. Best Pract. Res. Clin. Obstet. Gynaecol. 2003. 17: 707716.
  • 38
    Sugimoto, Y. and Narumiya, S., Prostaglandin E receptors. J. Biol. Chem. 2007. 282: 1161311617.
  • 39
    Blanco, J. C., Contursi, C., Salkowski, C. A., DeWitt, D. L., Ozato, K. and Vogel, S. N., Interferon regulatory factor (IRF)-1 and IRF-2 regulate interferon gamma-dependent cyclooxygenase 2 expression. J. Exp. Med. 2000. 191: 21312144.
  • 40
    Chen, C. C., Sun, Y. T., Chen, J. J. and Chiu, K. T., TNF-alpha-induced cyclooxygenase-2 expression in human lung epithelial cells: involvement of the phospholipase C-gamma 2, protein kinase C-alpha, tyrosine kinase, NF-kappa B-inducing kinase, and I-kappa B kinase 1/2 pathway. J. Immunol. 2000. 165: 27192728.
  • 41
    Harris, S. G., Padilla, J., Koumas, L., Ray, D. and Phipps, R. P., Prostaglandins as modulators of immunity. Trends Immunol. 2002. 23: 144150.
  • 42
    DeLong, P., Tanaka, T., Kruklitis, R., Henry, A. C., Kapoor, V., Kaiser, L. R., Sterman, D. H. and Albelda, S. M., Use of cyclooxygenase-2 inhibition to enhance the efficacy of immunotherapy. Cancer Res. 2003. 63: 78457852.
  • 43
    Blay, J., White, T. D. and Hoskin, D. W., The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine. Cancer Res. 1997. 57: 26022605.
  • 44
    Ren, G., Zhang, L., Zhao, X., Xu, G., Zhang, Y., Roberts, A. I., Zhao, R. C. and Shi, Y., Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2008. 2: 141150.
  • 45
    Le Blanc, K. and Ringden, O., Mesenchymal stem cells: properties and role in clinical bone marrow transplantation. Curr. Opin. Immunol. 2006. 18: 586591.
  • 46
    Djouad, F., Fritz, V., Apparailly, F., Louis-Plence, P., Bony, C., Sany, J., Jorgensen, C. and Noel, D., Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. Arthritis Rheum. 2005. 52: 15951603.
  • 47
    Zappia, E., Casazza, S., Pedemonte, E., Benvenuto, F., Bonanni, I., Gerdoni, E., Giunti, D. et al., Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 2005. 106: 17551761.
  • 48
    Rajan, A. J., Gao, Y. L., Raine, C. S. and Brosnan, C. F., A pathogenic role for gamma delta T-cells in relapsing-remitting experimental allergic encephalomyelitis in the SJL mouse. J. Immunol. 1996. 157: 941949.
  • 49
    Spahn, T. W., Issazadah, S., Salvin, A. J. and Weiner, H. L., Decreased severity of myelin oligodendrocyte glycoprotein peptide 33 - 35-induced experimental autoimmune encephalomyelitis in mice with a disrupted TCR delta chain gene. Eur. J. Immunol. 1999. 29: 40604071.
  • 50
    Battistini, L., Selmaj, K., Kowal, C., Ohmen, J., Modlin, R. L., Raine, C. S. and Brosnan, C. F., Multiple sclerosis: limited diversity of the V delta 2-J delta 3 T-cell receptor in chronic active lesions. Ann. Neurol. 1995. 37: 198203.
  • 51
    Shimonkevitz, R., Colburn, C., Burnham, J. A., Murray, R. S. and Kotzin, B. L., Clonal expansions of activated gamma/delta T-cells in recent-onset multiple sclerosis. Proc. Natl. Acad. Sci. USA 1993. 90: 923927.
  • 52
    Stinissen, P., Vandevyver, C., Medaer, R., Vandegaer, L., Nies, J., Tuyls, L., Hafler, D. A. et al., Increased frequency of gamma delta T-cells in cerebrospinal fluid and peripheral blood of patients with multiple sclerosis. Reactivity, cytotoxicity, and T-cell receptor V gene rearrangements. J. Immunol. 1995. 154: 48834894.
  • 53
    Dazzi, F., Ramasamy, R., Glennie, S., Jones, S. P. and Roberts, I., The role of mesenchymal stem cells in haemopoiesis. Blood Rev. 2006. 20: 161171.
  • 54
    Krampera, M., Cosmi, L., Angeli, R., Pasini, A., Liotta, F., Andreini, A., Santarlasci, V. et al., Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 2006. 24: 386398.
  • 55
    Fisch, P., Handgretinger, R. and Schaefer, H. E., Pure red cell aplasia. Br. J. Haematol. 2000. 111: 10101022.
  • 56
    Espinosa, E., Tabiasco, J., Hudrisier, D. and Fournie, J. J., Synaptic transfer by human gamma delta T-cells stimulated with soluble or cellular antigens. J. Immunol. 2002. 168: 63366343.